Author Archive for: John Davis

About John Davis

This author has not written his bio yet.
But we are proud to say that John Davis contributed 20 entries already.

Entries by John Davis

5 Questions with Per-Anders Abrahamsson and Gopal Badlani

Secretary Generals to the big Spring Meetings, European Association of Urology and the American Urological Association Every Spring, thousands of urologists gather in big cities with mega-venues to attend one or both of the annual congresses of the EAU and the AUA. These are big events with respect to release of the latest scientific trials, […]

EAU14 – Planning and executing a meeting session: perspective of the chairs

An interview with Prof. Noel Clarke on the EORTC-GU session For an academic and/or key opinion leader in urology, the opportunity to plan and execute a meeting session is a tremendous honor, but one that comes with numerous challenges. The trivial but not-so trivial aspects involve the logistics: who will attend, who will speak, what […]

EAU14 – ESOU citations

Have You Read This?…A bibliography of cited papers on prostate cancer at the Joint Meeting of The European Section of Oncological Surgery (ESOU) and EORTC—Genito-Urinary Cancer Group. At the BJUI, as with any journal, the published articles are peer reviewed and editorial board reviewed.  The process starts with a triage editor who screens for basic methodology, importance of the […]

EAU14 – The Multifaceted Goals Of Andrology: Maintaining Quality Of Life

A famous version of a saying attributed to Benjamin Franklin states “…but in this world nothing can be said to be certain, except death and taxes.” As a urologic oncologist, I cannot help with the taxes, but strive to delay the latter when threatened by urologic cancers.  Our colleagues in andrology, however, are charged with the task of […]

Another good week for radical prostatectomy

The SPCG-4 (Bill-Axelson) study updated again in NEJM In this week’s edition of the NEJM, Anna Bill-Axelson and the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) investigators have written an impressive update to their famous study comparing radical prostatectomy (RP) to watchful waiting (WW) in a setting of mostly clinically detected prostate cancer. In […]

What can a Society do to make you a better surgeon?

World Congress of Endourology 2013 — The Society of Urological Robotic Surgeons meeting report.   Continuing this theme, Dr. James Borin (Baltimore, USA) reviewed the Fundamentals of Robotic Surgery curriculum in development from a collaborative effort. This would be a device independent curriculum that covers didactics, psychomotor skills, and team building. This is a huge […]

Urological oncology in the BJUI

Urological oncology is increasingly multi-disciplinary, and hence competitive for high impact thought leadership. Innovation leading to paradigm changes may come from a number of different ideas and sources. Effective leadership in our specialty certainly requires technical innovations in surgical treatments, but also pivotal roles in improving the process of diagnosis, staging, patient counselling, multi-modal therapy, […]

Editorial: Salvaging failed radiation therapy: does the tumour location permit a less toxic approach?

In the introduction to their manuscript in this issue of the BJUI, Meeks et al. outline a significant challenge for physicians managing prostate cancer: from the estimated 240 000 diagnosed annually (USA) to the 120 000 choosing radiation, to the 40 000 estimated biochemical failures in the first 5 years who may benefit from additional local therapy to […]

Editorial: Oncological outcomes: open vs robotic prostatectomy

John W. Davis and Prokar Dasgupta* Departments of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA and *Guy’s Hospital, Kings College London, London, UK e-mail: [email protected] For men at significant risk of dying from untreated prostate cancer within reasonably estimated remaining life spans, which technique offers the best disease-free survival: open radical prostatectomy (RP) or robot-assisted […]

Editorial: What have we learned from the Partin table update?

The controversies surrounding a physician’s best treatment strategy advice to an individual patient with clinically localized prostate cancer create a continuing need for advanced statistics. Historically, the Partin tables [1] were one of the first statistical tools that physicians and patients found readily usable. The tables have been updated and always focused on prediction of […]

© 2024 BJU International. All Rights Reserved.